In this study, we examined the effects of MICAL1 on breast cancer cell proliferation and found that MICAL1 exhibits its effects by regulating cyclin D expressions via ROS‐sensitive PI3K/Akt/ERK signalling. Here, AKT1 is linked to breast cancer.